Cancer

Cancer

Cancer research

Clinical Trials

Performance of clinical trials is a departmental priority. The department and affiliated programs are conducting investigational studies of treatments for genitourinary cancer and other conditions with the goal of improving diagnosis, treatment, and follow-up of urologic disease. Learn more at the Helen Diller Family Comprehensive Cancer Center.

Learn More

UCSF is internationally known for its research in prostate and other urological cancers. Our department conducts basic scientific work to analyze and categorize different types of prostate cancer and the health risks they pose. Our faculty lead large epidemiological studies on dietary and other lifestyle interventions that may help reduce the risk of the disease. UCSF Urology also heads CaPSURE™, a multicenter longitudinal study of men with prostate cancer.

In addition to our work in prostate cancer, we have important research programs in bladder, renal and other urological cancers. The department conducts clinical trials of new treatments for genitourinary cancers, coordinated through the urologic clinical and translational science program. We also maintain a urologic oncology database, which provides a valuable repository of information to guide future investigations. Many of our faculty maintain research laboratories at UCSF, where they conduct basic science investigations in their areas of expertise.

Cancer News & Highlights

UCSF featured Urology researcher, Luke Gilbert, PhD highlighting NIH grant award for, "High-Risk, High Reward" research. Click here for full story. 
The presentation, “Genomic screening should be done,” presented by Matt Cooperberg, MD, MPH at the European Association of Urology 2018 conference held in March 2018 has been chosen as a Selected...
Tad Taube never does anything halfway. Concerned that the Holocaust overshadowed the centuries-long history of Jewish culture in Poland, Taube – a Jewish native of Krakow who escaped at age 8 just...
In a recent paper published in Urology author Paul Alpert, MD discusses his work, “New Evidence for the Benefit of PSA Screening: Data From 400,887 Kaiser Permanente Patients.” The study objective...
Welcome AUA 2018 to our great city.  Hope you have an opportunity to read through the AUA Daily News article written by UCSF pediatric urologist, Hillary Copp, MD, MS on what to see and do while in...
The United States Preventive Services Task Force (USPSTF) today announced a change in its recommendations for prostate-specific antigen (PSA) screening. Based on a reanalysis of data from two large...
UCSF Urology researchers Davide Ruggero, PhD and Hao Nguyen, MD, PhD, et al publish on promising new line of attack against lethal, treatment-resistant prostate cancer says Nicolas Weiler for UCSF....